Express News | "First A then H" trend rises, which may become Xiong'an New Power Technology in the Hong Kong stock IPO market.

BreakingsDec 21 03:22

Express News | Jiangsu Hengrui Pharmaceuticals: Injection SHR-1681 has received clinical trial approval.

BreakingsDec 20 16:32

Express News | A wave of listings in Hong Kong has begun, with multiple companies adopting the "A+H" model.

BreakingsDec 20 01:39

Jiangsu Hengrui Medicine Gets China Green Light for Bladder Cancer Drug Combo

MT NewswiresDec 19 15:30

Express News | Jiangsu Hengrui Pharmaceuticals: A subsidiary has received the notification of approval for a drug clinical trial.

BreakingsDec 18 16:38

Hengrui Medicine's Unit Included In Chinese Drug Administration's Breakthrough Therapy Drug List

MT NewswiresDec 17 12:11